115
Participants
Start Date
May 31, 2009
Primary Completion Date
May 31, 2013
Study Completion Date
December 31, 2015
Lanreotide
deep s.c. injection, 120 mg, every 4 weeks (±3 days).
Placebo
deep s.c. injection of placebo (0.9% saline solution) every 4 weeks (±3 days) for 16 weeks, then deep s.c. injection of lanreotide 120 mg, every 4 weeks (±3 days).
Paul Stradins Clinical University Hospital, Riga
GVI Oncology Clinical Trial Unit, Port Elizabeth
Rondebosch Oncology Unit, Cape Town
Clinic of Endocrinology, diabetes and metabolic diseases, Clinical Center of Serbia, Belgrade
VFN Onkologicka klinika, Prague
UPMC Liver Cancer Center, Pittsburgh
Penn State Milton S. Hershey Medical Center, Hershey
University of Pennsylvania, Philadelphia
Eastern Virginia Medical School, Norfolk
Erciyes University Medical Faculty, Kayseri
University of Mississippi Medical Center, Jackson
Kentuckiana Cancer Institute, Louisville
University of Michigan, Ann Arbor
Froedtert & Medical College of Wisconsin, Milwaukee
Chernivtsi Regional Oncology Center, Chernivtsi
Odessa Regional Clinical Hospital, Odesa
Louisiana State University Health Science Center, Kenner
Cedars Sinai Outpatient Cancer Center, West Hollywood
VA Greater Los Angeles Health Care System, Los Angeles
David Geffen School of Medicine at UCLA, Los Angeles
Stanford Cancer Center, Stanford
Providence Portland Medical Center, Portland
University of New Mexico Cancer Care Center, Albuquerque
Oregon Health Science University, Portland
Santokaba Durlabhji Memorial Hospital and Research Institute, Jaipur
Shatabdi Super Speciality hospital, Mumbai
Biocancer - Centro de Pesquisa e Tratamento do Câncer, Belo Horizonte
Hospital LifeCenter, Belo Horizonte
Oxion Medicina Oncológica, Belo Horizonte
Hospital Universitário de Brasilia, Brasília
Hospital Erasto Gaertner, Curitiba
Irmandade da Santa Casa de Misericórdia de Porto Alegre, Porto Alegre
Hospital de Base de São José do Rio Preto, São José do Rio Preto
Sir Gangaram Hospital, Delhi
Indo-American Cancer Institute & Research Centre, Hyderabad
Omega Hospitals, Hyderabad
Bhagwan Mahaveer cancer hospital and research centre, Jaipur
Tata Memorial Hospital, Mumbai
"Non-Federal Institution of Healthcare Central Clinical Hospital # 1 of the LLC Russian Railways (RZD)", Moscow
"Russian Academy of Medical Sciences Russian Oncological Research Centre named after N.N. Blokhin RAMS", Moscow
"Federal Institution of Healthcare Leningradsky Regional Oncological Dispensary", Saint Petersburg
Groote Schuur Hospital, Cape Town
Westridge Medical Centre, Durban
Cherkassy Regional Oncology Dispensary, Cherkassy
Oncology and Medical Radiology Chair of Dnepropetrovsk State Medical Academy, Dnipro
Regional Anticancer Center, Department of oncoproctology, Donetsk
Municipal Clinical Hospital #2, Proctology department, Kharkiv
Kyiv City Oncological Hospital, Thoracic department, Kyiv
"Medical Centre Mriya", Kyiv
National Cancer Institute, Kyiv
Uzhgorods'ka Tsentral'na Mis'ka Klinichna Likarnya, Mis'kyy Onkologichnyy Tsentr, Uzhhorod
Vinnytsya Regional Clinical Oncological Center, Vinnytsya State Medical University, Vinnytsia
Klinika Endokrynologii, Diabetologii i Leczenia Izotopami, Wroclaw
Oncology Institute of Vojvodina, Sremska Kamenica, Kamenitz
Lead Sponsor
Ipsen
INDUSTRY